Immediate Impact
5 standout
Citing Papers
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
2024 Standout
Role of p53 in breast cancer progression: An insight into p53 targeted therapy
2023 Standout
Works of Núria Álvarez being referenced
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Núria Álvarez | 8 | 4 | 28 | 18 | 14 | 4 | 41 | |
| R. Dunn | 10 | 4 | 23 | 18 | 4 | 5 | 32 | |
| M Hernández-García | 8 | 2 | 14 | 11 | 4 | 4 | 29 | |
| Jonathan Oh | 10 | 1 | 23 | 9 | 12 | 4 | 28 | |
| J. M�enp�� | 8 | 3 | 15 | 5 | 3 | 3 | 28 | |
| Jennifer M. Koziak | 6 | 4 | 14 | 29 | 5 | 3 | 45 | |
| Shanshan Yang | 13 | 23 | 12 | 20 | 5 | 4 | 47 | |
| Y. Unno | 33 | 4 | 17 | 4 | 20 | 5 | 48 | |
| Reyes Gonzalez-Exposito | 16 | 10 | 18 | 2 | 6 | 4 | 41 | |
| Julia Ciampa | 42 | 4 | 9 | 27 | 3 | 5 | 164 | |
| Saad Tahir | 5 | 10 | 23 | 5 | 3 | 4 | 29 |
All Works
Loading papers...